» Articles » PMID: 12241123

Histological and MR Correlations in Gliomatosis Cerebri

Overview
Journal J Neurooncol
Publisher Springer
Date 2002 Sep 21
PMID 12241123
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

The diagnosis of Gliomatosis cerebri (GC) is known to be difficult and is still a matter of debate. In order to better define this entity, we studied clinical, neuroradiological, pathological and follow-up data of 9 patients affected with GC. MRI were done with T1 before and after gadolinium injection, and with T2-weighted images and Flair in 3 cases. Histological confirmation of glial proliferation was obtained in all patients by craniotomy or stereotactic biopsies. Patients were treated and followed-up in our center. The histological analyses highlighted a heterogeneous glial proliferation with various degrees of anaplasia in all the cases including 2 cases of oligodendroglioma, 1 case of anaplastic oligodendroglioma, 2 cases of anaplastic mixed oligoastrocytoma, 1 case of anaplastic astrocytoma, 2 cases of glioblastoma and 1 case of astrocytic proliferation typical of GC. The topography of the tumoral infiltration was characteristic involving mainly the white matter, basal ganglia and thalamus, brainstem and less often hypothalamus. More than two cerebral lobes were involved. Contrast enhancement, mass effect and necrosis were minimal compared to the extent of tumoral infiltration. Patients were treated with various schemes of treatment all including nitrosourea. Survival from diagnosis was under one year except for 2 patients (17 and 14 months). This study shows that the diagnosis of GC needs to be based not on pathological data alone, but on pathological, clinical and, above all, on radiological criteria. Response to therapy could not clearly be observed in GC, despite oligodendroglial component in 6/9 cases. Prognosis of GC was constantly poor.

Citing Articles

An enduring debate on gliomatosis cerebri.

Akimoto J Brain Tumor Pathol. 2023; 40(2):78-84.

PMID: 37022648 DOI: 10.1007/s10014-023-00454-9.


Clinical, Imaging and Neurogenetic Features of Patients with Gliomatosis Cerebri Referred to a Tertiary Neuro-Oncology Centre.

Doig D, Thorne L, Rees J, Fersht N, Kosmin M, Brandner S J Pers Med. 2023; 13(2).

PMID: 36836456 PMC: 9960048. DOI: 10.3390/jpm13020222.


Leber's hereditary optic neuropathy with diffuse white matter changes mimicking gliomatosis cerebri: illustrative case.

Saruta W, Shibahara I, Handa H, Inukai M, Kanayama S, Yasumoto R J Neurosurg Case Lessons. 2022; 1(26):CASE21161.

PMID: 35854899 PMC: 9245756. DOI: 10.3171/CASE21161.


The splenium of the corpus callosum: embryology, anatomy, function and imaging with pathophysiological hypothesis.

Blaauw J, Meiners L Neuroradiology. 2020; 62(5):563-585.

PMID: 32062761 PMC: 7186255. DOI: 10.1007/s00234-019-02357-z.


Heterogeneity of glioblastoma with gliomatosis cerebri growth pattern on diffusion and perfusion MRI.

Forster A, Brehmer S, Seiz-Rosenhagen M, Mildenberger I, Giordano F, Wenz H J Neurooncol. 2018; 142(1):103-109.

PMID: 30565029 DOI: 10.1007/s11060-018-03068-w.


References
1.
Bendszus M, Warmuth-Metz M, Klein R, Burger R, Schichor C, Tonn J . MR spectroscopy in gliomatosis cerebri. AJNR Am J Neuroradiol. 2000; 21(2):375-80. PMC: 7975356. View

2.
Delisle M, Andrieu P, Geraud G, BOUISSOU H . [Cerebral gliomatosis. An anatomoclinical case]. Ann Pathol. 1989; 9(3):214-8. View

3.
Kleihues P, Burger P, Scheithauer B . The new WHO classification of brain tumours. Brain Pathol. 1993; 3(3):255-68. DOI: 10.1111/j.1750-3639.1993.tb00752.x. View

4.
Maintz D, Fiedler K, Koopmann J, Rollbrocker B, Nechev S, Lenartz D . Molecular genetic evidence for subtypes of oligoastrocytomas. J Neuropathol Exp Neurol. 1997; 56(10):1098-104. DOI: 10.1097/00005072-199710000-00003. View

5.
Schoenen J, de Leval L, REZNIK M . Gliomatosis cerebri: clinical, radiological and pathological report of a case with a stroke-like onset. Acta Neurol Belg. 1996; 96(4):294-300. View